Prelude Therapeutics Inc (PRLD) › Operating IncomePrelude Therapeutics Inc (PRLD) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$28.11M2020: -$58.76M2021: -$113.73M2022: -$123.54M2023: -$132.28M2024: -$139.71M2025: -$104.57M-$104.57M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$104.57M+25.2%2024-$139.71M-5.6%2023-$132.28M-7.1%2022-$123.54M-8.6%2021-$113.73M-93.5%2020-$58.76M-109.1%2019-$28.11M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share